Bridging low-molecular-weight heparin for temporary interruption of warfarin.
Shojania
A M
AM
D000925:Anticoagulants / Q000008:administration & dosage* / Q000493:pharmacokinetics; D017984:Enoxaparin / Q000008:administration & dosage* / Q000493:pharmacokinetics; D015951:Factor Xa / Q000378:metabolism*; D006801:Humans; D019934:International Normalized Ratio; D011300:Preoperative Care / Q000379:methods*; D014812:Vitamin K / Q000008:administration & dosage*; D014859:Warfarin / Q000627:therapeutic use; D028761:Withholding Treatment
D000925:Anticoagulants; D017984:Enoxaparin; D014812:Vitamin K; D014859:Warfarin; D015951:Factor Xa